These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20635916)

  • 1. Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies.
    Seiler T; Hiddemann W; Dreyling M
    Immunotherapy; 2009 Nov; 1(6):1015-24. PubMed ID: 20635916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
    Morschhauser F; Radford J; Van Hoof A; Vitolo U; Soubeyran P; Tilly H; Huijgens PC; Kolstad A; d'Amore F; Gonzalez Diaz M; Petrini M; Sebban C; Zinzani PL; van Oers MH; van Putten W; Bischof-Delaloye A; Rohatiner A; Salles G; Kuhlmann J; Hagenbeek A
    J Clin Oncol; 2008 Nov; 26(32):5156-64. PubMed ID: 18854568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunotherapy in follicular lymphoma.
    Illidge T; Morschhauser F
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):279-93. PubMed ID: 21658624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
    Witzig TE; Gordon LI; Cabanillas F; Czuczman MS; Emmanouilides C; Joyce R; Pohlman BL; Bartlett NL; Wiseman GA; Padre N; Grillo-López AJ; Multani P; White CA
    J Clin Oncol; 2002 May; 20(10):2453-63. PubMed ID: 12011122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?
    Illidge T; Chan C
    Leuk Lymphoma; 2008 Jul; 49(7):1263-73. PubMed ID: 18604715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab maintenance therapy in follicular lymphoma.
    Forstpointner R; Dreyling M
    Curr Hematol Malig Rep; 2007 Oct; 2(4):213-8. PubMed ID: 20425372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.
    Lazzarino M; Arcaini L; Orlandi E; Iacona I; Bernasconi P; Calatroni S; Varettoni M; Isa L; Brusamolino E; Bonfichi M; Passamonti F; Burcheri S; Pascutto C; Regazzi M
    Oncology; 2005; 68(2-3):146-53. PubMed ID: 16006752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab maintenance versus retreatment in follicular lymphoma.
    Palla AR; Hamadani M
    Hematol Oncol; 2013 Dec; 31(4):171-8. PubMed ID: 23044794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab combined with a small dose of melphalan for a refractory follicular lymphoma patient.
    Saigo K; Okumachi Y; Kondo S; Chinzei T; Okamura A; Takenokuchi M; Kawano S; Kumagai S
    Leuk Lymphoma; 2006 Feb; 47(2):353-6. PubMed ID: 16321871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study.
    Askeland G
    Expert Rev Clin Immunol; 2013 May; 9(5):402. PubMed ID: 23772446
    [No Abstract]   [Full Text] [Related]  

  • 11. Management options for follicular lymphoma: observe; R-CHOP; B-R; others?
    McLaughlin P
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S91-5. PubMed ID: 22035757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas.
    Domingo-Domènech E; González-Barca E; Estany C; Sureda A; Besalduch J; Fernández de Sevilla A
    Haematologica; 2002 Nov; 87(11):1229-30. PubMed ID: 12414357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proteins in haematology].
    Clarenbach RE; Mey U
    Ther Umsch; 2011 Nov; 68(11):610-7. PubMed ID: 22045523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone.
    Persky DO; Dornan D; Goldman BH; Braziel RM; Fisher RI; Leblanc M; Maloney DG; Press OW; Miller TP; Rimsza LM
    Haematologica; 2012 Jun; 97(6):937-42. PubMed ID: 22271896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [90Y-ibritumomab tiuxetan in patients with follicular lymphoma relapsing or refractory to rituximab].
    Aurer I; Huić D; Zuvić M; Sever-Prebilić M; Ajduković R; Radman I; Skare-Librenjak L; Ostojić-Kolonić S; Labar B
    Lijec Vjesn; 2006; 128(7-8):224-7. PubMed ID: 17087138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin's lymphoma and corrected with IVIG.
    Saikia TK; Menon H; Advani SH
    Ann Oncol; 2001 Oct; 12(10):1493-4. PubMed ID: 11762825
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged remission in a patient with relapsed follicular lymphoma after a single course of rituximab.
    Jensen M; Elter T; Engert A; Reiser M
    Onkologie; 2006 Mar; 29(3):90-2. PubMed ID: 16514269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma.
    Jacobs SA; Swerdlow SH; Kant J; Foon KA; Jankowitz R; Land SR; DeMonaco N; Joyce J; Osborn JL; Evans TL; Schaefer PM; Luong TM
    Clin Cancer Res; 2008 Nov; 14(21):7088-94. PubMed ID: 18981007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.
    Press OW; Unger JM; Braziel RM; Maloney DG; Miller TP; Leblanc M; Fisher RI;
    J Clin Oncol; 2006 Sep; 24(25):4143-9. PubMed ID: 16896003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of follicular non-Hodgkin's lymphoma.
    Maloney DG
    Curr Hematol Rep; 2005 Jan; 4(1):39-45. PubMed ID: 15610658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.